Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Transmucosal Drug Delivery Devices Market Growth 2022-2028

  • LP 4916311
  • 91 Pages
  • March 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Transmucosal Drug Delivery Devices will have significant change from previous year. According to our (LP Information) latest study, the global Transmucosal Drug Delivery Devices market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Transmucosal Drug Delivery Devices market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Transmucosal Drug Delivery Devices market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Transmucosal Drug Delivery Devices market, reaching US$ million by the year 2028. As for the Europe Transmucosal Drug Delivery Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Transmucosal Drug Delivery Devices players cover Allergan, Amphastar Pharmaceuticals Inc, Aquestive Therapeutics Inc, and ARS Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Transmucosal Drug Delivery Devices market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Buccal Route

Rectal Route

Nasal Route

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Residential

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Allergan

Amphastar Pharmaceuticals Inc

Aquestive Therapeutics Inc

ARS Pharmaceuticals

Combinent BioMedical Systems Inc

Aegis Therapeutics LLC

Bespak Europe Ltd

Callitas Therapeutics Inc

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Transmucosal Drug Delivery Devices Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Transmucosal Drug Delivery Devices by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Transmucosal Drug Delivery Devices by Country/Region, 2017, 2022 & 2028

2.2 Transmucosal Drug Delivery Devices Segment by Type

2.2.1 Buccal Route

2.2.2 Rectal Route

2.2.3 Nasal Route

2.3 Transmucosal Drug Delivery Devices Sales by Type

2.3.1 Global Transmucosal Drug Delivery Devices Sales Market Share by Type (2017-2022)

2.3.2 Global Transmucosal Drug Delivery Devices Revenue and Market Share by Type (2017-2022)

2.3.3 Global Transmucosal Drug Delivery Devices Sale Price by Type (2017-2022)

2.4 Transmucosal Drug Delivery Devices Segment by Application

2.4.1 Hospital

2.4.2 Residential

2.5 Transmucosal Drug Delivery Devices Sales by Application

2.5.1 Global Transmucosal Drug Delivery Devices Sale Market Share by Application (2017-2022)

2.5.2 Global Transmucosal Drug Delivery Devices Revenue and Market Share by Application (2017-2022)

2.5.3 Global Transmucosal Drug Delivery Devices Sale Price by Application (2017-2022)

3 Global Transmucosal Drug Delivery Devices by Company

3.1 Global Transmucosal Drug Delivery Devices Breakdown Data by Company

3.1.1 Global Transmucosal Drug Delivery Devices Annual Sales by Company (2020-2022)

3.1.2 Global Transmucosal Drug Delivery Devices Sales Market Share by Company (2020-2022)

3.2 Global Transmucosal Drug Delivery Devices Annual Revenue by Company (2020-2022)

3.2.1 Global Transmucosal Drug Delivery Devices Revenue by Company (2020-2022)

3.2.2 Global Transmucosal Drug Delivery Devices Revenue Market Share by Company (2020-2022)

3.3 Global Transmucosal Drug Delivery Devices Sale Price by Company

3.4 Key Manufacturers Transmucosal Drug Delivery Devices Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Transmucosal Drug Delivery Devices Product Location Distribution

3.4.2 Players Transmucosal Drug Delivery Devices Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Transmucosal Drug Delivery Devices by Geographic Region

4.1 World Historic Transmucosal Drug Delivery Devices Market Size by Geographic Region (2017-2022)

4.1.1 Global Transmucosal Drug Delivery Devices Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Transmucosal Drug Delivery Devices Annual Revenue by Geographic Region

4.2 World Historic Transmucosal Drug Delivery Devices Market Size by Country/Region (2017-2022)

4.2.1 Global Transmucosal Drug Delivery Devices Annual Sales by Country/Region (2017-2022)

4.2.2 Global Transmucosal Drug Delivery Devices Annual Revenue by Country/Region

4.3 Americas Transmucosal Drug Delivery Devices Sales Growth

4.4 APAC Transmucosal Drug Delivery Devices Sales Growth

4.5 Europe Transmucosal Drug Delivery Devices Sales Growth

4.6 Middle East & Africa Transmucosal Drug Delivery Devices Sales Growth

5 Americas

5.1 Americas Transmucosal Drug Delivery Devices Sales by Country

5.1.1 Americas Transmucosal Drug Delivery Devices Sales by Country (2017-2022)

5.1.2 Americas Transmucosal Drug Delivery Devices Revenue by Country (2017-2022)

5.2 Americas Transmucosal Drug Delivery Devices Sales by Type

5.3 Americas Transmucosal Drug Delivery Devices Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Transmucosal Drug Delivery Devices Sales by Region

6.1.1 APAC Transmucosal Drug Delivery Devices Sales by Region (2017-2022)

6.1.2 APAC Transmucosal Drug Delivery Devices Revenue by Region (2017-2022)

6.2 APAC Transmucosal Drug Delivery Devices Sales by Type

6.3 APAC Transmucosal Drug Delivery Devices Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Transmucosal Drug Delivery Devices by Country

7.1.1 Europe Transmucosal Drug Delivery Devices Sales by Country (2017-2022)

7.1.2 Europe Transmucosal Drug Delivery Devices Revenue by Country (2017-2022)

7.2 Europe Transmucosal Drug Delivery Devices Sales by Type

7.3 Europe Transmucosal Drug Delivery Devices Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Transmucosal Drug Delivery Devices by Country

8.1.1 Middle East & Africa Transmucosal Drug Delivery Devices Sales by Country (2017-2022)

8.1.2 Middle East & Africa Transmucosal Drug Delivery Devices Revenue by Country (2017-2022)

8.2 Middle East & Africa Transmucosal Drug Delivery Devices Sales by Type

8.3 Middle East & Africa Transmucosal Drug Delivery Devices Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Transmucosal Drug Delivery Devices

10.3 Manufacturing Process Analysis of Transmucosal Drug Delivery Devices

10.4 Industry Chain Structure of Transmucosal Drug Delivery Devices

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Transmucosal Drug Delivery Devices Distributors

11.3 Transmucosal Drug Delivery Devices Customer

12 World Forecast Review for Transmucosal Drug Delivery Devices by Geographic Region

12.1 Global Transmucosal Drug Delivery Devices Market Size Forecast by Region

12.1.1 Global Transmucosal Drug Delivery Devices Forecast by Region (2023-2028)

12.1.2 Global Transmucosal Drug Delivery Devices Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Transmucosal Drug Delivery Devices Forecast by Type

12.7 Global Transmucosal Drug Delivery Devices Forecast by Application

13 Key Players Analysis

13.1 Allergan

13.1.1 Allergan Company Information

13.1.2 Allergan Transmucosal Drug Delivery Devices Product Offered

13.1.3 Allergan Transmucosal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Allergan Main Business Overview

13.1.5 Allergan Latest Developments

13.2 Amphastar Pharmaceuticals Inc

13.2.1 Amphastar Pharmaceuticals Inc Company Information

13.2.2 Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Product Offered

13.2.3 Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Amphastar Pharmaceuticals Inc Main Business Overview

13.2.5 Amphastar Pharmaceuticals Inc Latest Developments

13.3 Aquestive Therapeutics Inc

13.3.1 Aquestive Therapeutics Inc Company Information

13.3.2 Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Product Offered

13.3.3 Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Aquestive Therapeutics Inc Main Business Overview

13.3.5 Aquestive Therapeutics Inc Latest Developments

13.4 ARS Pharmaceuticals

13.4.1 ARS Pharmaceuticals Company Information

13.4.2 ARS Pharmaceuticals Transmucosal Drug Delivery Devices Product Offered

13.4.3 ARS Pharmaceuticals Transmucosal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 ARS Pharmaceuticals Main Business Overview

13.4.5 ARS Pharmaceuticals Latest Developments

13.5 Combinent BioMedical Systems Inc

13.5.1 Combinent BioMedical Systems Inc Company Information

13.5.2 Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Product Offered

13.5.3 Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Combinent BioMedical Systems Inc Main Business Overview

13.5.5 Combinent BioMedical Systems Inc Latest Developments

13.6 Aegis Therapeutics LLC

13.6.1 Aegis Therapeutics LLC Company Information

13.6.2 Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Product Offered

13.6.3 Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Aegis Therapeutics LLC Main Business Overview

13.6.5 Aegis Therapeutics LLC Latest Developments

13.7 Bespak Europe Ltd

13.7.1 Bespak Europe Ltd Company Information

13.7.2 Bespak Europe Ltd Transmucosal Drug Delivery Devices Product Offered

13.7.3 Bespak Europe Ltd Transmucosal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Bespak Europe Ltd Main Business Overview

13.7.5 Bespak Europe Ltd Latest Developments

13.8 Callitas Therapeutics Inc

13.8.1 Callitas Therapeutics Inc Company Information

13.8.2 Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Product Offered

13.8.3 Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Callitas Therapeutics Inc Main Business Overview

13.8.5 Callitas Therapeutics Inc Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Transmucosal Drug Delivery Devices Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Transmucosal Drug Delivery Devices Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Buccal Route

Table 4. Major Players of Rectal Route

Table 5. Major Players of Nasal Route

Table 6. Global Transmucosal Drug Delivery Devices Sales by Type (2017-2022) & (K Units)

Table 7. Global Transmucosal Drug Delivery Devices Sales Market Share by Type (2017-2022)

Table 8. Global Transmucosal Drug Delivery Devices Revenue by Type (2017-2022) & ($ million)

Table 9. Global Transmucosal Drug Delivery Devices Revenue Market Share by Type (2017-2022)

Table 10. Global Transmucosal Drug Delivery Devices Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Transmucosal Drug Delivery Devices Sales by Application (2017-2022) & (K Units)

Table 12. Global Transmucosal Drug Delivery Devices Sales Market Share by Application (2017-2022)

Table 13. Global Transmucosal Drug Delivery Devices Revenue by Application (2017-2022)

Table 14. Global Transmucosal Drug Delivery Devices Revenue Market Share by Application (2017-2022)

Table 15. Global Transmucosal Drug Delivery Devices Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Transmucosal Drug Delivery Devices Sales by Company (2020-2022) & (K Units)

Table 17. Global Transmucosal Drug Delivery Devices Sales Market Share by Company (2020-2022)

Table 18. Global Transmucosal Drug Delivery Devices Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Transmucosal Drug Delivery Devices Revenue Market Share by Company (2020-2022)

Table 20. Global Transmucosal Drug Delivery Devices Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Transmucosal Drug Delivery Devices Producing Area Distribution and Sales Area

Table 22. Players Transmucosal Drug Delivery Devices Products Offered

Table 23. Transmucosal Drug Delivery Devices Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Transmucosal Drug Delivery Devices Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Transmucosal Drug Delivery Devices Sales Market Share Geographic Region (2017-2022)

Table 28. Global Transmucosal Drug Delivery Devices Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Transmucosal Drug Delivery Devices Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Transmucosal Drug Delivery Devices Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Transmucosal Drug Delivery Devices Sales Market Share by Country/Region (2017-2022)

Table 32. Global Transmucosal Drug Delivery Devices Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Transmucosal Drug Delivery Devices Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Transmucosal Drug Delivery Devices Sales by Country (2017-2022) & (K Units)

Table 35. Americas Transmucosal Drug Delivery Devices Sales Market Share by Country (2017-2022)

Table 36. Americas Transmucosal Drug Delivery Devices Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Transmucosal Drug Delivery Devices Revenue Market Share by Country (2017-2022)

Table 38. Americas Transmucosal Drug Delivery Devices Sales by Type (2017-2022) & (K Units)

Table 39. Americas Transmucosal Drug Delivery Devices Sales Market Share by Type (2017-2022)

Table 40. Americas Transmucosal Drug Delivery Devices Sales by Application (2017-2022) & (K Units)

Table 41. Americas Transmucosal Drug Delivery Devices Sales Market Share by Application (2017-2022)

Table 42. APAC Transmucosal Drug Delivery Devices Sales by Region (2017-2022) & (K Units)

Table 43. APAC Transmucosal Drug Delivery Devices Sales Market Share by Region (2017-2022)

Table 44. APAC Transmucosal Drug Delivery Devices Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Transmucosal Drug Delivery Devices Revenue Market Share by Region (2017-2022)

Table 46. APAC Transmucosal Drug Delivery Devices Sales by Type (2017-2022) & (K Units)

Table 47. APAC Transmucosal Drug Delivery Devices Sales Market Share by Type (2017-2022)

Table 48. APAC Transmucosal Drug Delivery Devices Sales by Application (2017-2022) & (K Units)

Table 49. APAC Transmucosal Drug Delivery Devices Sales Market Share by Application (2017-2022)

Table 50. Europe Transmucosal Drug Delivery Devices Sales by Country (2017-2022) & (K Units)

Table 51. Europe Transmucosal Drug Delivery Devices Sales Market Share by Country (2017-2022)

Table 52. Europe Transmucosal Drug Delivery Devices Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Transmucosal Drug Delivery Devices Revenue Market Share by Country (2017-2022)

Table 54. Europe Transmucosal Drug Delivery Devices Sales by Type (2017-2022) & (K Units)

Table 55. Europe Transmucosal Drug Delivery Devices Sales Market Share by Type (2017-2022)

Table 56. Europe Transmucosal Drug Delivery Devices Sales by Application (2017-2022) & (K Units)

Table 57. Europe Transmucosal Drug Delivery Devices Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Transmucosal Drug Delivery Devices Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Transmucosal Drug Delivery Devices Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Transmucosal Drug Delivery Devices Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Transmucosal Drug Delivery Devices Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Transmucosal Drug Delivery Devices Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Transmucosal Drug Delivery Devices Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Transmucosal Drug Delivery Devices Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Transmucosal Drug Delivery Devices Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Transmucosal Drug Delivery Devices

Table 67. Key Market Challenges & Risks of Transmucosal Drug Delivery Devices

Table 68. Key Industry Trends of Transmucosal Drug Delivery Devices

Table 69. Transmucosal Drug Delivery Devices Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Transmucosal Drug Delivery Devices Distributors List

Table 72. Transmucosal Drug Delivery Devices Customer List

Table 73. Global Transmucosal Drug Delivery Devices Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Transmucosal Drug Delivery Devices Sales Market Forecast by Region

Table 75. Global Transmucosal Drug Delivery Devices Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Transmucosal Drug Delivery Devices Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Transmucosal Drug Delivery Devices Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Transmucosal Drug Delivery Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Transmucosal Drug Delivery Devices Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Transmucosal Drug Delivery Devices Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Transmucosal Drug Delivery Devices Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Transmucosal Drug Delivery Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Transmucosal Drug Delivery Devices Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Transmucosal Drug Delivery Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Transmucosal Drug Delivery Devices Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Transmucosal Drug Delivery Devices Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Transmucosal Drug Delivery Devices Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Transmucosal Drug Delivery Devices Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Transmucosal Drug Delivery Devices Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Transmucosal Drug Delivery Devices Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Transmucosal Drug Delivery Devices Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Transmucosal Drug Delivery Devices Revenue Market Share Forecast by Application (2023-2028)

Table 93. Allergan Basic Information, Transmucosal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 94. Allergan Transmucosal Drug Delivery Devices Product Offered

Table 95. Allergan Transmucosal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Allergan Main Business

Table 97. Allergan Latest Developments

Table 98. Amphastar Pharmaceuticals Inc Basic Information, Transmucosal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 99. Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Product Offered

Table 100. Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Amphastar Pharmaceuticals Inc Main Business

Table 102. Amphastar Pharmaceuticals Inc Latest Developments

Table 103. Aquestive Therapeutics Inc Basic Information, Transmucosal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 104. Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Product Offered

Table 105. Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. Aquestive Therapeutics Inc Main Business

Table 107. Aquestive Therapeutics Inc Latest Developments

Table 108. ARS Pharmaceuticals Basic Information, Transmucosal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 109. ARS Pharmaceuticals Transmucosal Drug Delivery Devices Product Offered

Table 110. ARS Pharmaceuticals Transmucosal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. ARS Pharmaceuticals Main Business

Table 112. ARS Pharmaceuticals Latest Developments

Table 113. Combinent BioMedical Systems Inc Basic Information, Transmucosal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 114. Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Product Offered

Table 115. Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. Combinent BioMedical Systems Inc Main Business

Table 117. Combinent BioMedical Systems Inc Latest Developments

Table 118. Aegis Therapeutics LLC Basic Information, Transmucosal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 119. Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Product Offered

Table 120. Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. Aegis Therapeutics LLC Main Business

Table 122. Aegis Therapeutics LLC Latest Developments

Table 123. Bespak Europe Ltd Basic Information, Transmucosal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 124. Bespak Europe Ltd Transmucosal Drug Delivery Devices Product Offered

Table 125. Bespak Europe Ltd Transmucosal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. Bespak Europe Ltd Main Business

Table 127. Bespak Europe Ltd Latest Developments

Table 128. Callitas Therapeutics Inc Basic Information, Transmucosal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 129. Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Product Offered

Table 130. Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 131. Callitas Therapeutics Inc Main Business

Table 132. Callitas Therapeutics Inc Latest Developments

List of Figures

Figure 1. Picture of Transmucosal Drug Delivery Devices

Figure 2. Transmucosal Drug Delivery Devices Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Transmucosal Drug Delivery Devices Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Transmucosal Drug Delivery Devices Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Transmucosal Drug Delivery Devices Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Buccal Route

Figure 10. Product Picture of Rectal Route

Figure 11. Product Picture of Nasal Route

Figure 12. Global Transmucosal Drug Delivery Devices Sales Market Share by Type in 2021

Figure 13. Global Transmucosal Drug Delivery Devices Revenue Market Share by Type (2017-2022)

Figure 14. Transmucosal Drug Delivery Devices Consumed in Hospital

Figure 15. Global Transmucosal Drug Delivery Devices Market: Hospital (2017-2022) & (K Units)

Figure 16. Transmucosal Drug Delivery Devices Consumed in Residential

Figure 17. Global Transmucosal Drug Delivery Devices Market: Residential (2017-2022) & (K Units)

Figure 18. Global Transmucosal Drug Delivery Devices Sales Market Share by Application (2017-2022)

Figure 19. Global Transmucosal Drug Delivery Devices Revenue Market Share by Application in 2021

Figure 20. Transmucosal Drug Delivery Devices Revenue Market by Company in 2021 ($ Million)

Figure 21. Global Transmucosal Drug Delivery Devices Revenue Market Share by Company in 2021

Figure 22. Global Transmucosal Drug Delivery Devices Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global Transmucosal Drug Delivery Devices Revenue Market Share by Geographic Region in 2021

Figure 24. Global Transmucosal Drug Delivery Devices Sales Market Share by Region (2017-2022)

Figure 25. Global Transmucosal Drug Delivery Devices Revenue Market Share by Country/Region in 2021

Figure 26. Americas Transmucosal Drug Delivery Devices Sales 2017-2022 (K Units)

Figure 27. Americas Transmucosal Drug Delivery Devices Revenue 2017-2022 ($ Millions)

Figure 28. APAC Transmucosal Drug Delivery Devices Sales 2017-2022 (K Units)

Figure 29. APAC Transmucosal Drug Delivery Devices Revenue 2017-2022 ($ Millions)

Figure 30. Europe Transmucosal Drug Delivery Devices Sales 2017-2022 (K Units)

Figure 31. Europe Transmucosal Drug Delivery Devices Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa Transmucosal Drug Delivery Devices Sales 2017-2022 (K Units)

Figure 33. Middle East & Africa Transmucosal Drug Delivery Devices Revenue 2017-2022 ($ Millions)

Figure 34. Americas Transmucosal Drug Delivery Devices Sales Market Share by Country in 2021

Figure 35. Americas Transmucosal Drug Delivery Devices Revenue Market Share by Country in 2021

Figure 36. United States Transmucosal Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada Transmucosal Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico Transmucosal Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil Transmucosal Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC Transmucosal Drug Delivery Devices Sales Market Share by Region in 2021

Figure 41. APAC Transmucosal Drug Delivery Devices Revenue Market Share by Regions in 2021

Figure 42. China Transmucosal Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan Transmucosal Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea Transmucosal Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia Transmucosal Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 46. India Transmucosal Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia Transmucosal Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe Transmucosal Drug Delivery Devices Sales Market Share by Country in 2021

Figure 49. Europe Transmucosal Drug Delivery Devices Revenue Market Share by Country in 2021

Figure 50. Germany Transmucosal Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 51. France Transmucosal Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK Transmucosal Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy Transmucosal Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia Transmucosal Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa Transmucosal Drug Delivery Devices Sales Market Share by Country in 2021

Figure 56. Middle East & Africa Transmucosal Drug Delivery Devices Revenue Market Share by Country in 2021

Figure 57. Egypt Transmucosal Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa Transmucosal Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel Transmucosal Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey Transmucosal Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country Transmucosal Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of Transmucosal Drug Delivery Devices in 2021

Figure 63. Manufacturing Process Analysis of Transmucosal Drug Delivery Devices

Figure 64. Industry Chain Structure of Transmucosal Drug Delivery Devices

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450